• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MAOIs 处方实用指南:破除迷思,消除障碍。

Practical guide for prescribing MAOIs: debunking myths and removing barriers.

机构信息

Neuroscience Education Institute, Carlsbad, CA, USA.

出版信息

CNS Spectr. 2012 Mar;17(1):2-10. doi: 10.1017/S109285291200003X.

DOI:10.1017/S109285291200003X
PMID:22790112
Abstract

Despite the fact that monoamine oxidase inhibitors (MAOIs) can be highly effective therapeutic agents for depression and some anxiety disorders, they tend to be underutilized in clinical practice. This is due at least in part to the fact that there is a great deal of misinformation and mythology about their dietary and drug interactions. This article is intended to serve as a guide for clinicians who are not particularly familiar with MAO inhibitors; its aim is to help these clinicians competently integrate these agents into clinical practice when appropriate.

摘要

尽管单胺氧化酶抑制剂(MAOIs)对治疗抑郁症和一些焦虑症可能非常有效,但它们在临床实践中往往未被充分利用。这至少部分是由于关于它们的饮食和药物相互作用存在大量错误信息和神话。本文旨在为不太熟悉 MAO 抑制剂的临床医生提供指导;其目的是帮助这些临床医生在适当的时候将这些药物有效地整合到临床实践中。

相似文献

1
Practical guide for prescribing MAOIs: debunking myths and removing barriers.MAOIs 处方实用指南:破除迷思,消除障碍。
CNS Spectr. 2012 Mar;17(1):2-10. doi: 10.1017/S109285291200003X.
2
Monoamine oxidase inhibitors.单胺氧化酶抑制剂
Am Fam Physician. 1986 Jul;34(1):113-9.
3
Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification.对单胺氧化酶抑制剂有反应的焦虑症和恐惧症的描述:对分类的启示
J Clin Psychiatry. 1984 Jul;45(7 Pt 2):29-36.
4
MAOIs and depression treatment guidelines.MAOIs 和抑郁症治疗指南。
J Clin Psychiatry. 2012 Jul;73(7):e24. doi: 10.4088/JCP.11096tx4c.
5
Current place of monoamine oxidase inhibitors in the treatment of depression.单胺氧化酶抑制剂在抑郁症治疗中的现状。
CNS Drugs. 2013 Oct;27(10):789-97. doi: 10.1007/s40263-013-0097-3.
6
[Indications for therapy using MAO inhibitors].[使用单胺氧化酶抑制剂进行治疗的适应症]
Psychiatr Prax. 1989 Aug;16 Suppl 1:2-6.
7
[Reversible inhibitor of MAO-A(RIMA)].单胺氧化酶A可逆抑制剂(RIMA)
Nihon Rinsho. 2001 Aug;59(8):1530-4.
8
Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants.单胺氧化酶抑制剂:一类过时的抗抑郁药的现代指南。
CNS Spectr. 2008 Oct;13(10):855-70. doi: 10.1017/s1092852900016965.
9
The use of MAOIs in primary care.在初级保健中使用 MAOIs。
J Clin Psychiatry. 2012 May;73(5):e19. doi: 10.4088/JCP.11096tx8c.
10
MAOIs and transdermal delivery.MAOIs 和经皮给药。
J Clin Psychiatry. 2012 Sep;73(9):e28. doi: 10.4088/JCP.11096tx6c.

引用本文的文献

1
Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors.与单胺氧化酶抑制剂的临床相关药物相互作用
Health Psychol Res. 2022 Nov 3;10(4):39576. doi: 10.52965/001c.39576. eCollection 2022.
2
The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors.经典单胺氧化酶抑制剂诱导自发性高血压的痕量胺理论。
J Neural Transm (Vienna). 2021 Nov;128(11):1741-1756. doi: 10.1007/s00702-021-02399-9. Epub 2021 Aug 9.
3
Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively.
精神科实践中的单胺氧化酶抑制剂(MAOIs):如何安全有效地使用它们。
CNS Drugs. 2021 Jul;35(7):703-716. doi: 10.1007/s40263-021-00832-x. Epub 2021 Jul 9.
4
Antidepressants- and antipsychotics-induced hepatotoxicity.抗抑郁药和抗精神病药引起的肝毒性。
Arch Toxicol. 2021 Mar;95(3):767-789. doi: 10.1007/s00204-020-02963-4. Epub 2021 Jan 5.
5
In Reply: Spontaneous MAOI hypertensive reaction, not likely armodafinil - tranylcypromine interaction.回复:自发性单胺氧化酶抑制剂高血压反应,不太可能是阿得拉与反苯环丙胺的相互作用。
J Neurol Sci. 2019 Feb 15;397:172. doi: 10.1016/j.jns.2019.01.002. Epub 2019 Jan 8.
6
Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review.当代抗抑郁药物的副作用应对:全面综述
Chonnam Med J. 2018 May;54(2):101-112. doi: 10.4068/cmj.2018.54.2.101. Epub 2018 May 25.
7
New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson's Disease.治疗帕金森病非运动症状的新药理学方法
Curr Pharmacol Rep. 2016 Dec;2(6):253-261. doi: 10.1007/s40495-016-0071-0. Epub 2016 Sep 28.
8
Antidepressant efficacy and side-effect burden: a quick guide for clinicians.抗抑郁药的疗效与副作用负担:临床医生快速指南
Drugs Context. 2015 Oct 8;4:212290. doi: 10.7573/dic.212290. eCollection 2015.
9
Changes in intensity of serotonin syndrome caused by adverse interaction between monoamine oxidase inhibitors and serotonin reuptake blockers.单胺氧化酶抑制剂与5-羟色胺再摄取阻滞剂之间的不良相互作用所引起的血清素综合征强度变化。
Neuropsychopharmacology. 2014 Jul;39(8):1996-2007. doi: 10.1038/npp.2014.49. Epub 2014 Feb 28.
10
Ketamine as antidepressant? Current state and future perspectives.氯胺酮作为抗抑郁药?现状与未来展望。
Curr Neuropharmacol. 2014 Jan;12(1):57-70. doi: 10.2174/1570159X113119990043.